Package Leaflet: Information for the Patient
Donepezilo Teva 5 mg Film-Coated Tablets EFG
donepezilo, hydrochloride(as monohydrate)
Read this leaflet carefully before you start taking this medicine because it contains important information for you
- Keep this leaflet, as you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others even if their symptoms are the same. It may harm them.
- If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4
1. What Donepezilo Teva is and what it is used for
2. What you need to know before you start taking Donepezilo Teva
3. How to take Donepezilo Teva
4. Possible side effects
5. Storage of Donepezilo Teva
6. Contents of the pack and additional information
Donepezilo (donepezil hydrochloride) belongs to a group of medicines called acetylcholinesterase inhibitors.
Donepezil hydrochloride increases the levels in the brain of a substance (acetylcholine) involved in memory function by reducing the breakdown of acetylcholine.
It is used to treat the symptoms of dementia in people diagnosed with mild to moderately severe Alzheimer's disease. Symptoms include increased loss of memory, confusion, and changes in behavior. As a result, patients with Alzheimer's find it increasingly difficult to carry out their normal daily activities. It is for use only in adult patients.
Do not take Donepezilo Teva
- if you are allergic (hypersensitive) to donepezil hydrochloride or derivatives of piperidina or to any of the other components of this medication (listed in section 6).
Inform your doctor if any of these situations affect you.
Warnings and precautions
Donepezilo Teva treatment should only be initiated and monitored by a doctor with experience in the diagnosis and treatment of Alzheimer's disease.
Consult with your doctor or pharmacist before taking donepezil hydrochloride if you have or have had:
- stomach or duodenal ulcers
- a seizure or convulsion
- a heart condition (such as irregular or very slow heartbeats, heart failure, myocardial infarction)
- a heart condition called "prolongation of the QT interval" or a history of certain abnormal heart rhythms called torsade de pointes or if someone in your family has "prolongation of the QT interval"
- low levels of magnesium or potassium in the blood
- asthma or other long-term lung diseases
- liver problems or hepatitis
- difficulty urinating or mild kidney disease.
Also inform your doctor if you are pregnant or think you may be pregnant.
Use in children and adolescents
Donepezilo Teva is not recommended for use in children and adolescents under 18 years old.
Other medications and Donepezilo Teva
Inform your doctor or pharmacist if you are using or have used recently or may need to use any other medication.
This includes medications that your doctor has not prescribed but that you have purchased from a pharmacist. It also applies to medications that you may take in the future if you continue to take Donepezilo Teva. This is because these medications may weaken or strengthen the effects of Donepezilo Teva.
Especially, inform your doctor if you are taking any of the following medications:
- anticholinergics, for example Tolterodina
- anticonvulsants, for example phenytoin, carbamazepine
- muscle relaxants, for example diazepam, succinylcholine
- general anesthetics
- over-the-counter medications, for example, plant-based.
If you are to undergo surgery that requires general anesthesia, inform your doctor and the anesthesiologist that you are taking Donepezilo Teva. This is because your medication may affect the amount of anesthetic needed.
Donepezilo Teva may be used in patients with mild to moderate renal or hepatic disease.
Inform your doctor that you have kidney or liver disease. Patients with severe liver disease should not take Donepezilo Teva.
Tell your doctor or pharmacist the name of your caregiver. Your caregiver will help you take the medication as prescribed.
Taking Donepezilo Teva with food and alcohol
Food does not affect the absorption of donepezil hydrochloride. Do not drink alcohol while taking Donepezilo Teva because alcohol may change its effect.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
Donepezilo Teva should not be used during breastfeeding.
Driving and operating machinery
Alzheimer's disease may affect your ability to drive or operate machinery and should not be done unless your doctor indicates it is safe to do so.
It may also cause fatigue, dizziness, or muscle cramps, mainly at the start of treatment or when changing the dose. If you experience these effects while taking Donepezilo Teva tablets, do not drive or operate machinery.
Donepezilo Teva contains lactose
If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.
Donepezilo Teva contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Donepezilo Teva Dose Taking
The initial recommended dose is 5 mg (one white tablet) each night before going to bed. After a month, your doctor may tell you to take 10 mg (one yellow tablet) each night. The dose of the tablet you take may vary depending on how long you have been taking this medication and what your doctor recommends. The maximum recommended dose is 10 mg each night. Always follow the advice of your doctor or pharmacist on how and when to take your medication. Do not modify the dose yourself without consulting your doctor.
How to take your medication
Swallow your tablet with a little water at night before going to bed. If you have abnormal dreams, nightmares, or difficulty sleeping (see section 4), your doctor may recommend that you take donepezilo in the morning.
Use in children and adolescents
Donepezilo Teva is not recommended for use in children and adolescents under 18 years old.
If you take more Donepezilo Teva than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or go to the hospital or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested. Bring the tablets and the packaging to the hospital, so the doctor will know what you have taken.
The symptoms of overdose may include nausea and vomiting, drooling, sweating, decreased heart rate, low blood pressure (dizziness or dizziness when standing up), breathing problems, loss of consciousness, and seizures or convulsions.
If you forgot to take Donepezilo Teva
If you forgot to take your medication, take the next dose at the usual time. Do not take a double dose to compensate for the missed doses. If you forgot to take your medication for more than a week, call your doctor before taking more.
If you interrupt treatment with Donepezilo Teva
Do not stop taking the tablets unless your doctor has told you to. Your doctor or pharmacist will indicate for how long you should continue taking the tablets. You will need to see your doctor from time to time to review your treatment and evaluate your symptoms.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
How long should you take Donepezilo Teva
Your doctor or pharmacist will advise you on how long you should continue taking the tablets.
You will need to visit your doctor from time to time to review your treatment and evaluate your symptoms.
Like all medicines, Donepezilo Teva can cause side effects, although not everyone will experience them.
People who took Donepezilo Teva have reported the following side effects.
Inform your doctor if you experience any of these side effects while taking Donepezilo Teva.
Severe side effects:
Consult your doctor immediately if you notice these side effects mentioned. You may need urgent medical treatment.
• Liver damage, for example, hepatitis. Hepatitis symptoms are nausea (feeling unwell) or vomiting (being sick), loss of appetite, general discomfort, fever, itching, yellowing of the skin and eyes, and dark-colored urine (may affect up to 1 in 1,000 people).
• Stomach or duodenal ulcers. Ulcer symptoms are stomach pain and discomfort (indigestion), general discomfort between the navel and sternum (may affect up to 1 in 100 people).
• Bleeding in the stomach or intestines. This may cause your stools to turn from tar-black to visible blood in the rectum (may affect up to 1 in 100 people).
• Seizures or convulsions (may affect up to 1 in 100 people).
• Fever with muscle stiffness, sweating, or a decrease in level of consciousness (a condition called "Neuroleptic Malignant Syndrome") (may affect up to 1 in 10,000 people).
•Weakness, sensitivity, or muscle pain, particularly if you are feeling unwell, have a fever, or have dark-colored urine. This may be due to abnormal muscle destruction that can be fatal and cause kidney problems (a condition called rhabdomyolysis) (may affect up to 1 in 10,000 people).
Other side effects
Very common (may affect more than 1 in 10 people)
• Diarrhea,
• Headache,
Common (may affect up to 1 in 10 people)
• Insomnia (difficulty sleeping)
• Common cold
• Loss of appetite
• Hallucinations (seeing or hearing things that are not real),
• Unusual dreams and nightmares,
• Restlessness,
• Aggressive behavior,
• Fainting,
• Dizziness,
• Uncomfortable stomach sensation,
• Muscle cramps,
• Urinary incontinence,
• Pain,
• Accidents (patients are more prone to falls and accidents).
Uncommon (may affect up to 1 in 100 people)
• Decreased heart rate
• Excessive salivation
Rare (may affect up to 1 in 1,000 people)
• Rigidity, tremors, or uncontrollable movements, especially of the face and tongue but also of the limbs.
• Increased libido, hypersexuality
• Pisa syndrome (a condition that involves involuntary muscle contraction with abnormal flexion of the body and head to one side).
Reporting side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:
https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after theabbreviation CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging andmedicines that you no longer need at the SIGRE collection point at the pharmacy. If in doubt, askyour pharmacist how to dispose of the packaging and medicines that you no longer need. By doingso, you will help protect the environment.
Composition of Donepezilo Teva 5 mg film-coated tablets.
- The active ingredient is donepezil hydrochloride. Each tablet contains 5 mg of donepezil hydrochloride.
- The other components are:
Core: maize starch, lactose monohydrate, microcrystalline cellulose, sodium glycolate, type A, anhydrous colloidal silica, magnesium stearate.
Coating: lactose monohydrate, hypromellose 15cp, titanium dioxide (E-171) and macrogol 4000.
Appearance of the product and contents of the package
Donepezilo Teva 5 mg: film-coated tablets, white or almost white, round, biconvex, and marked with "DN 5" on one side.
Film-coated tablets are supplied in blister packs of 7, 28, 30, 50, 56, 60, 84, 90, 98 or 120 film-coated tablets.
Film-coated tablets are supplied in calendar blister packs of 7, 28, 56, 84 or 98 film-coated tablets.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Teva Pharma, S.L.U.
Anabel Segura 11, Edificio Albatros B 1st floor
28108 Alcobendas, Madrid (Spain)
Responsible manufacturer
Teva Operations Poland Sp. z.o.o
ul. Mogilska 80. 31-456, Cracow
Poland
or
PLIVA CROATIA LIMITED (PLIVA KRVATSKA D.O.O.)
Prilaz Baruna Filipovica, 25
10000 Zagreb, Croatia
or
Merckle GmbH
Ludwig-Merckle-Str. 3,
89143 Blaubeuren
Germany
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
BelgiumDonepezil Teva 5 mg filmomhulde tabletten
GermanyDonepezil-HCl AbZ5 mg Filmtabletten
FranceDonépézil TEVA 5 mg comprimé pelliculé
IrelandDonepezil Teva 5 mg film-coated tablets
ItalyDonepezil Teva
PortugalDonepezilo Teva
SloveniaDonepezil Pliva 5 mg filmsko obložene tablete
SpainDonepezilo Teva 5 mg comprimidos recubiertos con película EFG
This leaflet was approved in November 2022
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.